|
|
||||||||
,
-methylene-ATP in cat
pulmonary, mesenteric, and hindquarter vascular beds
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112
Responses to the P2X-purinoceptor
agonist
,
-methylene-ATP (
,
-MeATP) were investigated in the
pulmonary, hindquarter, and mesenteric vascular beds in the
cat. Under constant-flow conditions, injections of
,
-MeATP caused dose-related increases in perfusion pressure in
the pulmonary and hindquarter beds and a biphasic response in the
mesenteric circulation. In the pulmonary vascular bed, the order of
potency was
,
-MeATP > U-46619 > angiotensin II,
whereas, in the hindquarters, the order of potency was angiotensin II > U-46619 >
,
-MeATP. The order of potency was
similar in the hindquarter and mesenteric beds when the pressor
component of the response to
,
-MeATP was compared with responses
to angiotensin II and U-46619. The P2X-receptor antagonist
pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid attenuated the
pressor response to
,
-MeATP in the hindquarter circulation and
the pressor component in the mesenteric vascular bed. Pressor responses
to
,
-MeATP were not altered by cyclooxygenase,
-adrenergic, or
angiotensin AT1 antagonists. These data show that
,
-MeATP has potent pressor activity in the pulmonary circulation, where it was 100-fold more potent than angiotensin II. In contrast,
,
-MeATP had modest pressor activity in the systemic bed, where it
was 1,000-fold less potent than angiotensin II. These data suggest that
responses to
,
-MeATP are dependent on the vascular bed studied
and may be dependent on the density of P2X receptors in the vascular bed.
vasoconstrictor; pulmonary and peripheral vascular bed; pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid
This article has been cited by other articles:
![]() |
A. E. Kindig, S. G. Hayes, and M. P. Kaufman Purinergic 2 receptor blockade prevents the responses of group IV afferents to post-contraction circulatory occlusion J. Physiol., January 1, 2007; 578(1): 301 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Geary, H. Akinbi, T. Korfhagen, J.-E. Fabre, R. Boucher, and W. Rice Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L890 - L895. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Buckwalter, J. J. Hamann, and P. S. Clifford Vasoconstriction in active skeletal muscles: a potential role for P2X purinergic receptors? J Appl Physiol, September 1, 2003; 95(3): 953 - 959. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |